search
Company Information
HKD
6.78
- (0.3%)
SEHK:01093, CSPC PHARMACEUTICAL GROUP LIMITED
Industry: Drug Manufacturers - General
End of Day: 6 May 2024 GMT+8
CSPC Pharmaceutical Group listed on the Hong Kong Stock Exchange in 1994 and is one of the largest pharmaceutical companies in China. Its biggest business segment is the finished drugs segment which accounts for nearly 80% of its total revenue. Now it has a diversified pipeline portfolio in seven therapeutic areas including nervous system diseases, oncology, anti-infective to cardiovascular disease, respiratory system disease, and metabolism. CSPC also has a bulk drug product segment including vitamin C, antibiotics, and a caffeine series.

Address

No. 226 Huanghe Street
Hebei Province

Classification

Sector

Healthcare

Industry Group

Drug Manufacturers

Industry

Drug Manufacturers - General

Key Executives

Mr. Chun Kwok Alan Au
Director
Mr. Cheuk Kin Stephen Law
Director
Mr. Dongchen Cai
Chairman of the Board/Co-CEO/Director
Mr. Cuilong Zhang
Co-CEO/Director/Vice Chairman of the Board
Mr. Zhenguo Wang
Director
Mr. Weidong Pan
Director
Mr. Huaiyu Wang
Director
Dr. Chunlei Li
Director
Dr. Qingxi Wang
Director
Mr. Kin Man Chak
Director
Dr. Hao Jiang
Director
Mr. Bo Wang
Director
Mr. Chuan Chen
Director
Professor Hongguang Wang
Director
Ms. Quan Li
Director

Ownership

Institution Holdings

Vanguard Group Inc
277,978,631 (2.335%)
UBS Asset Management (HK) Ltd.
242,570,960 (2.038%)
UBS Asset Management
223,979,200 (1.882%)
First Sentier Investors (Hong Kong) Limited
161,236,974 (1.355%)
BlackRock Fund Advisors
161,035,791 (1.353%)
Bosera Asset Management Co., Limited
108,516,000 (0.912%)
State Street Global Advisors Asia Ltd
95,055,869 (0.799%)
UBS Asset Management (Hong Kong) Limited
89,880,952 (0.755%)
Ninety One UK Limited
82,755,520 (0.695%)
BlackRock Advisors (UK) Limited
79,140,173 (0.665%)

Funds Holdings

Vanguard Total Intl Stock Idx Fund
114,486,056 (0.962%)
Vanguard Instl Ttl Intl Stk Mkt Idx TrII
55,104,213 (0.463%)
JPM China Fund
48,276,000 (0.406%)
Hang Seng China Enterprises ETF
41,986,020 (0.353%)
UBS (Lux) EF Greater China (USD)
39,519,760 (0.332%)
Hang Seng Index Tracking Fund
29,083,812 (0.244%)
iShares MSCI China ETF
26,622,400 (0.224%)
UBS SDIC HK Value Discovery Alloc
24,935,840 (0.209%)
Harvest HK Advantage Alloc
24,714,000 (0.208%)
iShares MSCI EM SRI ETF
24,112,000 (0.203%)

Details

Overview Company Info Key Ratios Income Balance Sheet Cash Flow
Make Smart Investment Choices